Skip to main content
. 2021 Apr 9;30(9):2633–2647. doi: 10.1007/s11136-021-02833-1

Table 2.

Outcome measure scores, floor and ceiling effects at baseline across trial-arms

Short name N (%) Mean Median SD P. floor/
worst score
P. ceiling/
best score
O
worst score
O
best score
N floor/
worst score (%)
N ceiling/
best score (%)
PHQ-9 361 (100) 14.332 14 4.991 27 0 27 2 1 (0.3) 0 (0)
GAD-7 361 (100) 12.623 13 4.521 21 0 21 0 10 (2.8) 1 (0.3)
EQ-5D-5L VSE 355 (98.3) 0.730 0.783 0.163 − 0.285 1 − 0.010 1 0 (0) 3 (0.8)
EQ-5D-5L cross-walk 355 (98.3) 0.652 0.721 0.202 − 0.594 1 0.076 1 0 (0) 3 (0.8)
ReQoL-UI 353 (97.8) 0.778 0.807 0.141 − 0.195 1 0.115 0.995 0 (0) 0 (0)
ReQoL-10 353 (97.8) 18.598 18 6.401 0 40 3 37 0 (0) 0 (0)
EQ-5D-5L depression/anxiety 355 (98.3) 3.259 3 0.827 5 1 5 1 26 (7.3) 3 (0.8)

The table shows the possible (P.) floor/worst and ceiling/best scores as well as the observed (O.) worst and best scores achieved by the respondents; these are shown rather than possible and observed minimum and maximum scores due to the fact that for the preference-based scores a higher score is a better state, whereas for the condition-specific scores the opposite is true (i.e. a higher score is a worst state)

EQ-5D-5L EQ-5D Five Level version, GAD-7 generalised anxiety disorder-7, N number of responder, O. observed, PHQ-9 Patient Health Questionnaire-9, P. possible, ReQoL-UI(-10) Recovering Quality of Life—Utility Index (10 item), SD standard deviation